A carregar...
Optimizing Early “Go/No Go” Decisions in CNS Drug Development
Go/No Go decisions concerning development of any single compound determine investment in increasingly costly studies from Phase 1–3. Such decisions are problematic for CNS drug development where the variety of molecular targets in the brain have stimulated decades of studies without major therapeuti...
Na minha lista:
| Publicado no: | Expert Rev Clin Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648539/ https://ncbi.nlm.nih.gov/pubmed/25537256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17512433.2015.991715 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|